Advocacy Alert: Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One

April 8, 2021

On April 1, 2021, the Office of National Drug Control Policy released its statement of drug policy priorities for the Biden-Harris administration's first year.

These priorities "take a bold approach to reducing overdoses and saving lives," according to the statement. These priorities are:

• Expanding access to evidence-based treatment;
• Advancing racial equity issues in their approach to drug policy;
• Enhancing evidence-based harm reduction efforts;
• Supporting evidence-based prevention efforts to reduce youth substance use;
• Reducing the supply of illicit substances;
• Advancing recovery-ready workplaces and expanding the addiction workforce; and
• Expanding access to recovery support services.

According to the statement, "The Biden-Harris Administration’s multi-faceted and evidence-based approach will meet this challenge by expanding access to prevention, harm reduction, treatment, and recovery services, and reducing the supply of illicit substances."

You can read the full policy as a PDF here.

Questions? Concerns?

As always, we want your input.

A reminder that BHAP members get regular access to our advocate in Washington, DC. If you have any questions about BHAP's advocacy efforts, please contact us.